Zacks Small Cap Research on MSN
SNGX: Positive results for Phase 2a trial in psoriasis
(NASDAQ:SNGX) announced positive results from Cohort 3 of its ongoing Phase 2a trial of SGX302 (synthetic hypericin) for the ...
For too long, financial advisors have been making asset allocation decisions for their clients according to a “risk score,” a figure developed around client questionnaires to determine how much risk ...
Carrie Madormo, RN, MPH, is a health writer. She has over a decade of experience as a registered nurse, practicing in a variety of fields, such as pediatrics, oncology, chronic pain, and public health ...
In the mid-1990s, researchers identified the viral helicase–primase enzyme complex as a target for a potential anti-herpes simplex virus (HSV) therapy. Three decades later, the first promising ...
Apiiro, the leading application security posture management (ASPM) platform, is unveiling a new, AI-driven capability that detects risks during the design phase of the application development ...
A polygenic risk score (PRS) based on genes associated with endothelial cell function identifies patients at a higher risk of coronary artery disease, according to a new study. The risk score, which ...
A risk-assessment tool incorporating NT-proBNP and high-sensitivity troponin performs better than clinical scores for predicting stroke among patients with atrial fibrillation (AF) who are taking oral ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results